Inmune Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inmune Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Inmune Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $335K, a 24.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $335K -$109K -24.6% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $363K -$105K -22.4% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $389K -$96K -19.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $414K -$93K -18.3% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $444K -$85K -16.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $468K -$182K -28% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $485K -$196K -28.8% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $507K -$219K -30.2% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $529K +$401K +313% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $650K +$513K +374% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $681K +$534K +363% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $726K +$570K +365% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $128K -$37.4K -22.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $137K -$37.6K -21.6% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $147K -$35.7K -19.5% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $156K -$35.5K -18.6% Dec 31, 2020 10-K 2022-03-03
Q3 2020 $165K -$33.8K -17% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $175K -$34.6K -16.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $183K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $192K Dec 31, 2019 10-K 2021-03-04
Q3 2019 $199K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $209K Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.